Citius Oncology Enters Material Definitive Agreement
Ticker: CTOR · Form: 8-K · Filed: Apr 3, 2025 · CIK: 1851484
| Field | Detail |
|---|---|
| Company | Citius Oncology, INC. (CTOR) |
| Form Type | 8-K |
| Filed Date | Apr 3, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, corporate-action
TL;DR
Citius Oncology just signed a big deal, filing an 8-K on 3/28/25.
AI Summary
On March 28, 2025, Citius Oncology, Inc. entered into a material definitive agreement. The company, formerly known as TenX Keane Acquisition until March 15, 2021, is incorporated in Delaware and has its principal executive offices in Cranford, NJ.
Why It Matters
This filing indicates a significant new contract or partnership for Citius Oncology, which could impact its future operations and financial performance.
Risk Assessment
Risk Level: medium — Entering into a material definitive agreement can carry significant risks depending on the nature and terms of the agreement, which are not fully detailed in this initial filing.
Key Players & Entities
- CITIUS ONCOLOGY, INC. (company) — Registrant
- TenX Keane Acquisition (company) — Former company name
- March 15, 2021 (date) — Date of former company name change
- March 28, 2025 (date) — Date of earliest event reported
- 11 Commerce Drive, 1st Floor, Cranford, NJ 07016 (location) — Principal executive offices address
FAQ
What type of material definitive agreement did Citius Oncology, Inc. enter into?
The filing states that Citius Oncology, Inc. entered into a material definitive agreement on March 28, 2025, but the specific details of the agreement are not provided in this initial 8-K filing.
When was Citius Oncology, Inc. formerly known as TenX Keane Acquisition?
Citius Oncology, Inc. was formerly known as TenX Keane Acquisition until March 15, 2021.
Where are Citius Oncology, Inc.'s principal executive offices located?
The principal executive offices of Citius Oncology, Inc. are located at 11 Commerce Drive, 1st Floor, Cranford, NJ 07016.
What is the SIC code for Citius Oncology, Inc.?
The Standard Industrial Classification (SIC) code for Citius Oncology, Inc. is 2834, which corresponds to Pharmaceutical Preparations.
What is the filing date for this 8-K report?
This 8-K report was filed as of April 3, 2025, with the earliest event reported on March 28, 2025.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 3, 2025 regarding CITIUS ONCOLOGY, INC. (CTOR).